Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/119042
Full metadata record
DC FieldValueLanguage
dc.creatorMereiter, S
dc.creatorMagalhães, A
dc.creatorAdamczyk, B.
dc.creatorJin, C
dc.creatorAlmeida, A
dc.creatorDrici, L
dc.creatorIbáñez-Vea, M
dc.creatorGomes, C
dc.creatorFerreira, JA
dc.creatorAfonso, L
dc.creatorSantos, L
dc.creatorLarsen, M
dc.creatorKolarich, D
dc.creatorKarlsson, N
dc.creatorReis, CA
dc.date.accessioned2019-02-21T12:16:22Z-
dc.date.available2019-02-21T12:16:22Z-
dc.date.issued2016
dc.identifier.issn0304-4165
dc.identifier.urihttps://hdl.handle.net/10216/119042-
dc.description.abstractBackground Terminal a2-3 and a2-6 sialylation of glycans precludes further chain elongation, leading to the biosynthesis of cancer relevant epitopes such as sialyl-Lewis X (SLe X ). SLe X overexpression is associated with tumor aggressive phenotype and patients' poor prognosis. Methods MKN45 gastric carcinoma cells transfected with the sialyltransferase ST3GAL4 were established as a model overexpressing sialylated terminal glycans. We have evaluated at the structural level the glycome and the sialoproteome of this gastric cancer cell line applying liquid chromatography and mass spectrometry. We further validated an identified target expression by proximity ligation assay in gastric tumors. Results Our results showed that ST3GAL4 overexpression leads to several glycosylation alterations, including reduced O-glycan extension and decreased bisected and increased branched N-glycans. A shift from a2-6 towards a2-3 linked sialylated N-glycans was also observed. Sialoproteomic analysis further identified 47 proteins with significantly increased sialylated N-glycans. These included integrins, insulin receptor, carcinoembryonic antigens and RON receptor tyrosine kinase, which are proteins known to be key players in malignancy. Further analysis of RON confirmed its modification with SLe X and the concomitant activation. SLe X and RON co-expression was validated in gastric tumors. Conclusion The overexpression of ST3GAL4 interferes with the overall glycophenotype of cancer cells affecting a multitude of key proteins involved in malignancy. Aberrant glycosylation of the RON receptor was shown as an alternative mechanism of oncogenic activation. General significance This study provides novel targets and points to an integrative tumor glycomic/proteomic-profiling for gastric cancer patients' stratification. This article is part of a Special Issue entitled "Glycans in personalised medicine" Guest Editor: Professor Gordan Lauc.
dc.description.sponsorshipWe acknowledge the support from the European Union, Seventh Framework Programme, Gastric Glyco Explorer initial training network: grant number 316929. IPATIMUP integrates the i3S Research Unit, which is partially supported by FCT, the Portuguese Foundation for Science and Technology. This work is funded by FEDER funds through the Operational Programme for Competitiveness Factors-COMPETE (FCOMP-01-0124-FEDER028188) and National Funds through the FCT-Foundation for Science and Technology, under the projects: PEst-C/SAU/LA0003/2013, PTDC/BBB-EBI/0786/2012, and PTDC/BBB-EBI/0567/2014 (to CAR). This work was also supported by"Glycoproteomics" project grant number PCIG09-GA-2011-293847(to DK) and the Danish Natural Science Research Council and a generous grant from the VILLUM Foundation to the VILLUM Center for Bioanalytical Sciences at the University of Southern Denmark (to MRL). Grants were received from FCT, POPH (Programa Operacional Potencial Humano) and FSE (Fundo Social Europeu): SFRH/BPD/75871/2011 to AM; SFRH/BPD/111048/2015 to JAF; SFRH/BPD/96510/2013 to CG. The UPLC instrument was obtained with a grant from the Ingabritt and Arne Lundbergs Research Foundation (to NK). C.J. was supported by the Knut and Alice Wallenberg Foundation. The mass spectrometer (LTQ) was obtained by a grant from the Swedish Research Council (342-2004-4434) (to NK).
dc.language.isoeng
dc.publisherElsevier
dc.relationinfo:eu-repo/grantAgreement/FCT/COMPETE/132983/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/COMPETE/125428/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F75871%2F2011/PT
dc.relationinfo:eu-repo/grantAgreement/FCT/SFRH/SFRH%2FBPD%2F96510%2F2013/PT
dc.relation.ispartofBiochimica et Biophysica Acta - General Subjects, vol.1860(8), p. 1795-1808
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/legalcode
dc.subjectGene Expression Regulation, Enzymologic
dc.subjectGene Expression Regulation, Neoplastic
dc.subjectGlycomics
dc.subjectHumans
dc.subjectLewis X Antigen/biosynthesis
dc.subjectLewis X Antigen/genetics
dc.subjectNeoplasm Proteins/biosynthesis
dc.subjectNeoplasm Proteins/genetics
dc.subjectPolysaccharides/biosynthesis
dc.subjectPolysaccharides/genetics
dc.subjectReceptor Protein-Tyrosine Kinases/genetics
dc.subjectReceptor Protein-Tyrosine Kinases/metabolism
dc.subjectSialyltransferases/biosynthesis
dc.subjectSialyltransferases/genetics
dc.subjectStomach
dc.subjectNeoplasms/genetics
dc.subjectStomach Neoplasms/metabolism
dc.titleGlycomic analysis of gastric carcinoma cells discloses glycans as modulators of RON receptor tyrosine kinase activation in cancer
dc.typeArtigo em Revista Científica Internacional
dc.contributor.uportoInstituto de Investigação e Inovação em Saúde
dc.identifier.doi10.1016/j.bbagen.2015.12.016
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S0304416515003554?via%3Dihub
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
Mereiter S.pdf1.67 MBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons